Search Results 1501-1510 of 15586 for Orange Peel tea

1. A Study To Evaluate Dapagliflozin To Improve The LIVEs Of Patients With PReserved Ejection Fraction Heart Failure - Mayo Clinic

   Active malignancy requiring treatment (with the exception of basal cell or squamous cell carcinomas of the skin). Acute or chronic liver disease with severe ...

2. A 52-week Study Of Rilzabrutinib Efficacy And Safety Compared To Placebo In Adults Diagnosed With IgG4-related Disease - Mayo Clinic

   ... skin. * Known or suspected immunodeficiency, including history of invasive opportunistic infections (eg, histoplasmosis, listeriosis, coccidioidomycosis ...

3. Placebo Controlled Study Of VS-6063 In Subjects With Malignant Pleural Mesothelioma - Mayo Clinic

   Adequately treated noninvasive,non-melanoma skin cancers as well as in situ carcinoma of the cervix within the last 5 years will be allowed. Prior treatment ...

4. A Study Using The New TLR8 Agonist VTX-2337 And Cyclophosphamide In Treating Patients With Metastatic, Persistent, Recurrent, Or Progressive Solid Tumors - Mayo Clinic

   History of other invasive malignancy, with the exception of non-melanoma skin cancer and well-excised cervical carcinoma in situ, =< 3 years prior to ...

5. Accelerated Vs Standard BEP Chemotherapy For Patients With Intermediate And Poor-risk Metastatic Germ Cell Tumours - Mayo Clinic

   Other primary malignancy (EXCEPT adequately treated non-melanomatous carcinoma of the skin, germ cell tumour, or other malignancy treated at least 5 years ...

6. A Study To Evaluate EFT508 Alone And In Combination With Avelumab In Subjects With MSS Colorectal Cancer - Mayo Clinic

   About this study. This is a Phase 2, open-label, 2-part, multicenter study in subjects with MSS relapsed/refractory colorectal cancer.

7. Efficacy And Safety Of Intravenous Efzofitimod In Patients With Pulmonary Sarcoidosis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma - Mayo Clinic

   Basal or squamous cell skin cancer. No evidence of organic brain syndrome or significant impairment of basal cognitive function or any psychiatric disorder ...

9. TRC-PAD Program: In-Clinic Trial-Ready Cohort

   History within the last 3 years of a primary or recurrent malignant disease with the exception of non-melanoma skin cancers, resected cutaneous squamous ...

10. An Extension Protocol For Multiple Sclerosis Patients Who Participated In Genzyme-Sponsored Studies Of Alemtuzumab - Mayo Clinic

    2. To examine the safety and efficacy of initial alemtuzumab treatment in this study for patients who received Rebif® (interferon beta-1a) as their study ...